Skip to content
Recall Observatory FDA recall evidence

Drug product

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

D-0710-2018

April 17, 2018

Class III

Product summary

Firm
Rhodes Pharmaceuticals, L.P.
Event
Event 79820
Status
Terminated
Classification
Class III
Quantity
2454 bottles
Official record key
drug-enforcement:D-0710-2018

Official wording

Reason: Failed Dissolution Specification: Low dissolution outside of specifications

Code information: Lot# AG8679B Exp. 01/2020

Distribution pattern: Nationwide within the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specification